Navigation Links
Brain drain of dentists from Kerala to Britain

In an attempt to fulfill the shortage of Dentists in Britain, many Indian dentists, particularly those in Kerala, are busy training for an examination that could get them jobs abroad. //

Amit Patel, joint managing director of the Karnataka-based Manipal Bapuji Postgraduate Medical (& Dental) Faculty Pvt. Ltd (MBPMF), said there were close to 4,000 vacancies of dentists in Britain.

"India is one country which the National Health Service in the UK look towards because the dentistry course (in our country) is almost similar to the one there," Patel told IANS.

MBPMF is perhaps the only training organisation in the country that provides courses for dentists to take the three part international qualifying exam (IQE) for getting a Britain-approved license.

The courses, which began in February this year, are taught at Manipal in Karnataka. "Our fifth batch of training for the IQE is beginning in December. Since February, 270 dentists have undergone the training, of which 18 have already got jobs in UK," Patel told IANS on phone.

Many of those enrolling for the course are from Kerala, which is known to send a large number of health professionals abroad.

"A good number of the dentists who have taken the training so far are Keralites," said Patel.

Since the IQE has three parts, it usually takes close to a year for any dentist to qualify. To write each part of the IQE, the candidate has to go to Britain.

Sudhin K. Thomas, a post-graduate dentist and a faculty member at a private dental college in Uttar Pradesh who has just completed training for the first part, said the course was excellent.

Reports indicate that the pass percentage of those who have attended the course at MBPMF is close to 80 percent.

The training fee for the first part is Rs.120,000, for the second part Rs.155,000 and for the final Rs.200,000.


'"/>




Page: 1

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Brain death – How to cope with it
3. “Brain fingerprinting”- The new lie detectr
4. Nasal Spray Could Take Drugs Direct to Brain.
5. Virus Combats Brain Tumour
6. Nasal Spray Could Take Drugs Directly to Brain
7. Control of anger disorder connected to Brain Dysfunction
8. High Levels of Protein Linked to Brain Shrinkage
9. Brain damage affects artistic skill
10. Brain cells protected by new compounds
11. Brain changes observed in people with sleep apnoea
Post Your Comments:
(Date:1/7/2009)...rk for ER patients with hypoxia remains unclear , ...ing to the world,s most elevated natural laborator...hat the established medical rules about the amount...wrong. , "Some people can tolerate extremely low l...d Dr. Michael P.W. Grocott, from University Colleg...
(Date:1/7/2009)...nt Increase in Patients Unable to Pay Out-of-Pocke...iting Hospital ERs , , SACRAMENTO, Calif., Jan. 7... having a dramatic impact on California,s communit... report by the California Hospital Association (CH...onducted in November 2008 among hospital chief fin...
(Date:1/7/2009)...t failure, slowed cell growth, study says , ... a drug used for many years to treat irregular hea...-fighting agent, researchers report. , Cancer cell... many of these cells are oxygen-deprived and need ...ypoxia-inducible factor (HIF-1), which help cells ...
(Date:1/7/2009)...le at Albertsons stores throughout AR, AZ, CO, FL,...n,s LLC announced an expansion of its Albertsons ...y by introducing a new offering of $10.99 for a 90...n, Albertsons has added new generic medications to...covered by this discount program. Additional medi...
Breaking Medicine News(10 mins):Health News:Study of Everest Climbers Questions Oxygen Use 2Health News:Study of Everest Climbers Questions Oxygen Use 3Health News:Economic Downturn Takes Toll on California Hospitals 2Health News:Heart Drug May Be a Cancer Fighter 2Health News:Albertson's LLC Launches $10.99 for 90-day Supply of Generic Drugs as Part of Rx-tra Savings Prescription Discount Program 2
...cientists have reported a breakthrough, towards th...eclampsia.// The researchers from the US National...lampsia had high levels of two proteins several mo...Reporting their findings they explained that the t...
...uicide is the third leading cause of death in Cana...It is also a prevalent problem within Aboriginal c...proaching on September 10, 2006, two experts from ... are available to comment on the health challenges...
...he U.N. children's agency, UNICEF and the Barcelon... the team has agreed to donate $1.9 million a year...leged children with AIDS in developing countries. ...ds the AIDS programs in Swaziland, a poverty stric...
...hikungunya has re-emerged in the country after a p...Maharashtra, Andhra, Tamil Nadu and Kerala. Recent...hikungunya fever. Mosquitoes are the carriers who...o human. The National Institute of Communicable D...
Other Medicine News:Health News:Placental Proteins Could Be Responsible For Pre-eclampsia 2Health News:Getting Serious About Suicide Prevention 2
(Date:1/7/2009)...-- ImQuest Life Sciences announced today the succe... and Drug Administration to initiate human clinica...tor IQP-0410. ImQuest anticipates initiating their...-0410 is a novel small molecule inhibitor of HIV w...nscriptase inhibitor (NNRTI). The compound possess...
(Date:1/6/2009)...s from prior U.S., U.K. and China Trials , , SA...nc. (VTI), a development stage company targeting l...as begun for a randomized, controlled, multi-cente...acorporeal Liver Assist Device (ELAD) as a treatme...er three protocols. The study is open for enrollme...
(Date:1/6/2009)...SNewswire/ -- Sequella, Inc., a clinical-stage bio...emic potential, announced today that SQ109, its le...s (TB), was the first drug approved for evaluation...ynport Vaccine Company LLC and Quintiles Transnati...ute of Allergy and Infectious Diseases (NIAID), Na...
(Date:1/5/2009)...lene Pharmaceuticals announced today that it has i...protein kinase inhibitor, CX-4945, in patients wit...ultiple myeloma. The primary endpoints of the oral..., tolerance and PK properties of CX-4945 and to se...addition, multiple mechanism-related pharmacodynam...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3National Cancer Registrars Association and IMPAC Medical Systems Announce Best Paper Award Recipients 5035 1National Cancer Registrars Association and IMPAC Medical Systems Announce Best Paper Award Recipients 5035 2National Cancer Registrars Association and IMPAC Medical Systems Announce Best Paper Award Recipients 5035 3Richard A Schatz M D Joins Cardiums Scientific Advisory Board 5032 1Richard A Schatz M D Joins Cardiums Scientific Advisory Board 5032 2Richard A Schatz M D Joins Cardiums Scientific Advisory Board 5032 3Richard A Schatz M D Joins Cardiums Scientific Advisory Board 5032 4Rutgers research partner Stemcyte Inc expands to New Jersey 18164 1Rutgers research partner Stemcyte Inc expands to New Jersey 18164 2Go Speed Racer 21 Revving up the worlds fastest nanomotors 18161 1
... Rheumatoid Factor IgM enzyme linked immunosorbent...(RF IgM). Enzyme-linked immunosorbent assay method...M Rheumatoid Factor in human serum. The results of...gnosis of Rheumatoid Arthritis when supported by o...
Rheumatoid Factor , R1: 4 X 20 ml buffer, R2: 2 X 8 ml antibody, Test / Kit: 320 (H717)
...r is a high precision optical system for corneal t...terior eye segment, based on a Revolving Dual Chan...GALILEI combines the advantages of two technologie...re data, while Scheimpflug imaging is optimal for ...
EXTEND is an absorbable synthetic punctal implant that provides occlusion up to three months. It is packaged 20 implants per box in sizes of .0.3mm, 0.4mm, 0.5mm. A variety pack in also available w
Medicine Products: